Demystifying HbA1c testing at the point of care and the impacts of COVID-19 on patients with diabetes

Today, many medical providers are hesitant to adopt a point of care testing model for chronic disease management. During this webinar, our esteemed panel will discuss, in general, the differences between central lab and point of care testing, before moving the conversation into specifics about the benefits of testing for HbA1c at a point of care facility. In addition, we will discuss the stringent quality standards in place for HbA1c POC testing and the impact that a simplified user interface of these instruments can have on both the operator and patient experience. Lastly, we want to discuss what a COVID-19 diagnosis means for a patient with diabetes and what potential health impacts could follow.

Following this webinar, you will be able to:

• List the key benefits of HbA1c point-of-care testing.
• Identify the quality measures HbA1c instruments must adhere to throughout the product lifecycle.
• Identify possible long-term health implications of COVID-19 on those living with Diabetes.

Learning level

Intermediate: Refresher course; some basic knowledge required – for the experienced staff technologists with some years of experience.

Accreditation statement

SelectScience is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.^® Program.

Attendees of this one-hour webinar are also entitled to 1.0 ACCENT Continuing Education Credits from the AACC. This activity was planned in accordance with ACCENT^® Standards and Policies. Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email education@aacc.org.

Certificate of attendance

All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.